<p>Patients were grouped according to the number of fulfilled parameters (corticosteroids therapy, number of circulating lymphocytes <1875/μl, plasma BAFF levels <1011 pg/ml and RF-IgM >52.1 U/ml). Good response was reached in 20.8% of RA patients that fulfilled 0–1 parameter, in 29.2% of subjects that fulfilled 2–3 parameters and in 54.5% of subjects that fulfilled 4 parameters (Fisher's exact test between 4 parameters and 0–3 = <i>0.08</i>). Moderate-response was reached in 41.7% of RA patients that fulfilled 0–1 parameter, in 54.5% of subjects that fulfilled 2–3 parameters and in 72.7% of subjects that fulfilled 4 parameters (χ2 test = 3.02, df = 2; <i>p = 0.22</i>). *<i>p = 0.046</i>: percentage of good response in patients fulfilling 4...
Objectives: To identify the clinical factors predicting a good clinical response to anti-TNF therapy...
Background: Most composite indices of disease activity and response criteria in RA have been validat...
OBJECTIVES: To identify the clinical factors predicting a good clinical response to anti-TNF the...
Objective: To identify the clinical factors predicting failure or a good clinical response in the co...
<p>A cohort of early RA patients (n = 73) were recruited for investigation. Baseline characteristics...
<p>RA = rheumatoidarthritis; RF = rheumatoidfactor; DMARDs = disease-modifyingantirheumaticdrugs; A...
<p>Values are mean values (SD) or number of patients (%).</p>1<p>Eular Guideline: 1st rheumatologist...
Objective: Predictors of response to biologics in rheumatoid arthritis (RA) is an important issue in...
<p>(A) DAS28 and (B) the absolute number of CD4+CD161+ T-cells from RA patients at baseline (newly d...
OBJECTIVES: We explored clinical factors associated with a major response to rituximab (RTX) (e.g. A...
*<p>RA, rheumatoid arthritis; Mean [SD], mean ± standard deviation; RF, IgM rheumatoid factor; Anti-...
<p>Values are mean ± sd unless otherwise indicated. *values are reported as mean ± sd (median).</p><...
Objectives. To evaluate the prevalence of clinical remission and minimal disease activity according ...
Objectives. To study treatment response rates of RA patients undergoing second- and third-line anti-...
Objectives: Measurement of MRP8/14 serum levels has shown potential in predicting clinical response ...
Objectives: To identify the clinical factors predicting a good clinical response to anti-TNF therapy...
Background: Most composite indices of disease activity and response criteria in RA have been validat...
OBJECTIVES: To identify the clinical factors predicting a good clinical response to anti-TNF the...
Objective: To identify the clinical factors predicting failure or a good clinical response in the co...
<p>A cohort of early RA patients (n = 73) were recruited for investigation. Baseline characteristics...
<p>RA = rheumatoidarthritis; RF = rheumatoidfactor; DMARDs = disease-modifyingantirheumaticdrugs; A...
<p>Values are mean values (SD) or number of patients (%).</p>1<p>Eular Guideline: 1st rheumatologist...
Objective: Predictors of response to biologics in rheumatoid arthritis (RA) is an important issue in...
<p>(A) DAS28 and (B) the absolute number of CD4+CD161+ T-cells from RA patients at baseline (newly d...
OBJECTIVES: We explored clinical factors associated with a major response to rituximab (RTX) (e.g. A...
*<p>RA, rheumatoid arthritis; Mean [SD], mean ± standard deviation; RF, IgM rheumatoid factor; Anti-...
<p>Values are mean ± sd unless otherwise indicated. *values are reported as mean ± sd (median).</p><...
Objectives. To evaluate the prevalence of clinical remission and minimal disease activity according ...
Objectives. To study treatment response rates of RA patients undergoing second- and third-line anti-...
Objectives: Measurement of MRP8/14 serum levels has shown potential in predicting clinical response ...
Objectives: To identify the clinical factors predicting a good clinical response to anti-TNF therapy...
Background: Most composite indices of disease activity and response criteria in RA have been validat...
OBJECTIVES: To identify the clinical factors predicting a good clinical response to anti-TNF the...